Journal of Tuberculosis and Lung Disease ›› 2022, Vol. 3 ›› Issue (2): 118-124.doi: 10.19983/j.issn.2096-8493.20210166
Previous Articles Next Articles
ZHU Dan1, CHEN Yan2, SHUANG Qing-cui1, ZENG Hui-hui2()
Received:
2022-01-01
Online:
2022-06-30
Published:
2022-04-18
Contact:
ZENG Hui-hui
E-mail:bonemarrow@csu.edu.cn
Supported by:
CLC Number:
ZHU Dan, CHEN Yan, SHUANG Qing-cui, ZENG Hui-hui. Clinical observation of patients with acute axcerbation of chronic obstructive pulmonary disease and patients with chronic obstructive pulmonary disease plus community-acquired pneumonia[J]. Journal of Tuberculosis and Lung Disease , 2022, 3(2): 118-124. doi: 10.19983/j.issn.2096-8493.20210166
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.jtbld.cn/EN/10.19983/j.issn.2096-8493.20210166
临床特征 | AECOPD组(42例) | COPD合并CAP组(59例) | 统计检验值 | P值 | ||
---|---|---|---|---|---|---|
性别[例(构成比,%)] | χ2=0.944 | 0.944 | ||||
女 | 3(7.1) | 4(6.8) | ||||
男 | 39(92.9) | 55(93.2) | ||||
年龄(岁,$\bar{x}$±s) | 68.71±9.26 | 71.26±9.25 | t=-1.199 | 0.233 | ||
吸烟[例(构成比,%)] | χ2=3.042 | 0.218 | ||||
吸烟 | 28(66.6) | 42(71.2) | ||||
无吸烟史 | 7(16.7) | 11(18.6) | ||||
戒烟大于3年 | 7(16.7) | 6(10.2) | ||||
咳痰[例(构成比,%)] | χ2=0.059 | 0.807 | ||||
有 | 41(97.6) | 57(96.6) | ||||
无 | 1(2.4) | 2(3.4) | ||||
畏寒[例(发生率,%)] | 1(2.4) | 9(15.3) | χ2=4.558 | 0.033 | ||
发热[例(发生率,%)] | 4(9.5) | 16(27.1) | χ2=3.448 | 0.043 | ||
临床特征 | AECOPD组(42例) | COPD合并CAP组(59例) | 统计检验值 | P值 | ||
胸痛[例(发生率,%)] | 3(7.1) | 2(3.4) | χ2=0.734 | 0.391 | ||
呼吸频率(次/min, | 22.59±2.67 | 22.44±2.66 | t=0.223 | 0.824 | ||
体质量(kg, | 59.17±10.04 | 54.54±9.78 | t=2.152 | 0.375 | ||
肺部啰音[例(发生率,%)] | 27(64.3) | 49(83.1) | χ2=11.053 | 0.001 | ||
双下肢水肿[例(发生率,%)] | 10(23.8) | 17(28.8) | χ2=0.314 | 0.575 |
实验室检查 | AECOPD组(42例) | COPD合并CAP组(59例) | 统计检验值 | P值 |
---|---|---|---|---|
WBC[×109/L,M(Q1,Q3)] | 6.93(5.31,10.34) | 7.24(6.01,9.17) | Z=-0.544 | 0.586 |
N%( | 71.57±9.91 | 75.67±12.03 | t=-1.814 | 0.073 |
CRP[mg/L,M(Q1,Q3)] | 5.62(2.94,13.95) | 34.10(7.37,79.30) | Z=-4.648 | 0.000 |
PCT[ng/ml,M(Q1,Q3)] | 0.10(0.04,0.22) | 0.17(0.09,0.25) | Z=-0.818 | 0.024 |
ESR[mm/h,M(Q1,Q3)] | 18.50(8.00,27.00) | 32.00(14.00,53.00) | Z=-3.182 | 0.001 |
HGB(g/L, | 133.43±26.55 | 125.64±21.22 | t=1.636 | 0.105 |
ALB(g/L, | 38.05±4.09 | 33.18±4.06 | t=5.930 | 0.207 |
ALT[IU/L,M(Q1,Q3)] | 12.00(5.68,35.70) | 13.2(9.50,26.00) | Z=-0.912 | 0.056 |
AST[IU/L,M(Q1,Q3)] | 32.60(20.35,40.10) | 20.3(15.30,27.80) | Z=-0.906 | 0.365 |
BUN(mmol/L, | 6.00±2.06 | 6.36±2.59 | t=-0.599 | 0.549 |
SCr[μmol/L,M(Q1,Q3)] | 75.90(68.43,87.10) | 69.75(60.75,86.50) | Z=-1.645 | 0.100 |
BNP[pg/ml,M(Q1,Q3)] | 150.70(100.00,547.00) | 430.00(140.00,2253.00) | Z=-3.172 | 0.002 |
PaO2 (mmHg, | 42.00±16.75 | 77.28±26.49 | t=0.019 | 0.724 |
PaCO2(mmHg, | 45.71±9.94 | 51.26±16.15 | t=-3.621 | 0.035 |
合并症 | AECOPD组(42例) | COPD合并CAP组(59例) | χ2值 | P值 |
---|---|---|---|---|
脓毒血症[例(发生率,%)] | 1(2.4) | 3(5.1) | 0.472 | 0.492 |
感染性休克[例(发生率,%)] | 1(2.4) | 4(6.8) | 1.009 | 0.315 |
心力衰竭[例(发生率,%)] | 5(11.9) | 17(28.8) | 1.719 | 0.042 |
慢性肾功能不全[例(发生率,%)] | 0(0.0) | 2(3.4) | 1.452 | 0.228 |
肺大疱[例(发生率,%)] | 12(28.6) | 14(23.7) | 0.080 | 0.778 |
肺心病[例(发生率,%)] | 9(21.4) | 18(30.5) | 1.033 | 0.310 |
2型糖尿病[例(发生率,%)] | 4(9.5) | 6(10.2) | 0.011 | 0.915 |
高血压病[例(发生率,%)] | 9(21.4) | 16(27.1) | 0.426 | 0.514 |
[1] |
Vestbo J, Hurd SS, Agusti AG, et al. Global strategy for the diagnosis,management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med, 2013, 187(4):347-365. doi: 10.1164/rccm.201204-0596PP.
doi: 10.1164/rccm.201204-0596PP URL |
[2] |
Yin P, Wang H, Vos T, et al. A subnational analysis of mortality and prevalence of COPD in China from 1990 to 2013: findings from the global burden of disease study 2013. Chest, 2016, 150(6):1269-1280. doi: 10.1016/j.chest.2016.08.1474.
doi: 10.1016/j.chest.2016.08.1474 URL |
[3] |
Wang C, Xu J, Yang L et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study. Lancet, 2018, 391(10131):1706-17117. doi: 10.1016/S0140-6736(18)30841-9.
doi: 10.1016/S0140-6736(18)30841-9 URL |
[4] |
Ritchie AI, Wedzicha JA. Definition, Causes, Pathogenesis, and Consequences of Chronic Obstructive Pulmonary Disease Exacerbations. Clin Chest Med, 2020, 41(3):421-438. doi: 10.1016/j.ccm.2020.06.007.
doi: S0272-5231(20)30040-X pmid: 32800196 |
[5] |
Ryan M, Suaya JA, Chapman JD, et al. Incidence and cost of pneumonia in older adults with COPD in the United States. PLoS One, 2013, 8(10):e75887. doi: 10.1371/journal.pone.0075887.
doi: 10.1371/journal.pone.0075887 URL |
[6] |
Loke YK, Kwok CS, Wong JM, et al. Chronic obstructive pulmonary disease and mortality from pneumonia: meta-analysis. Int J Clin Pract, 2013, 67(5):477-487. doi: 10.1111/ijcp.12120.
doi: 10.1111/ijcp.12120 pmid: 23574107 |
[7] |
Sibila O, Anzueto A, Restrepo MI. The paradoxical effect on pneumonia of chronic inhaled corticosteroids. Clin Pulm Med, 2013, 20(1):10. 1097/CPM.0b013e31827a2a60. doi: 10.1097/CPM.0b013e31827a2a60.
doi: 10.1097/CPM.0b013e31827a2a60 |
[8] |
Criner GJ, Bourbeau J, Diekemper RL, et al. Prevention of Acute Exacerbations of COPD:American College of Chest Physicians and Canadian Thoracic Society Guideline. Chest, 2015, 147(4):894-942. doi: 10.1378/chest.14-1676.
doi: 10.1378/chest.14-1676 URL |
[9] |
中华医学会呼吸病学分会慢性阻塞性肺疾病学组, 中国医师协会呼吸医师分会慢性阻塞性肺疾病工作委员会. 慢性阻塞性肺疾病诊治指南(2021年修订版). 中华结核和呼吸杂志, 2021, 44(3):170-205. doi: 10.3760/cma.j.cn112147-20210109-00031.
doi: 10.3760/cma.j.cn112147-20210109-00031 |
[10] |
中华医学会呼吸病学分会. 中国成人社区获得性肺炎诊断和治疗指南(2016年版). 中华结核和呼吸杂志, 2016, 39(4):1-27. doi: 10.3760/cma.j.issn.1001-0939.2016.04.005.
doi: 10.3760/cma.j.issn.1001-0939.2016.04.005 |
[11] |
Kocsis B, Szabo D. New treatment options for lower respiratory tract infections. Expert Opin Pharmacother, 2017, 18(13):1345-1355. doi: 10.1080/14656566.2017.1363179.
doi: 10.1080/14656566.2017.1363179 pmid: 28762839 |
[12] |
Mahashur A. Management of lower respiratory tract infection in outpatient settings: Focus on clarithromycin. Lung India, 2018, 35(2):143-149. doi: 10.4103/lungindia.lungindia_262_17.
doi: 10.4103/lungindia.lungindia_262_17 pmid: 29487250 |
[13] |
Jiang HL, Chen HX, Liu W, et al. Is COPD associated with increased mortality and morbidity in hospitalized pneumonia? A systematic review and meta-analysis. Respirology, 2015, 20(7):1046-1054. doi: 10.1111/resp.12597.
doi: 10.1111/resp.12597 URL |
[14] |
Barker BL, Haldar K, Patel H, et al. Association between pathogens detected using quantitative polymerase chain reaction with airway inflammation in COPD at stable state and exacerbations. Chest, 2015, 147(1):46-55. doi: 10.1378/chest.14-0764.
doi: 10.1378/chest.14-0764 URL |
[15] |
Çolak A, Yılmaz C, Toprak B, et al. Procalcitonin and CRP as Biomarkers in Discrimination of Community-acquired Pneumonia and Exacerbation of COPD. J Med Biochem, 2017, 36(2):122-126. doi: 10.1515/jomb-2017-0011.
doi: 10.1515/jomb-2017-0011 URL |
[16] |
Li Y, Xie L, Xin S, et al. Values of procalcitonin and C-reactive proteins in the diagnosis and treatment of chronic obstructive pulmonary disease having concomitant bacterial infection. Pak J Med Sci, 2017, 33(3):566-569. doi: 10.12669/pjms.333.12554.
doi: 10.12669/pjms.333.12554 |
[17] |
Gao D, Chen X, Wu H, et al. The levels of serum pro-calcitonin and high-sensitivity C-reactive protein in the early diagnosis of chronic obstructive pulmonary disease during acute exacerbation. Exp Ther Med, 2017, 14(1):193-198. doi: 10.3892/etm.2017.4496.
doi: 10.3892/etm.2017.4496 URL |
[18] |
Gupta D, Agarwal R, Aggarwal AN, et al. Guidelines for diagnosis and management of chronic obstructive pulmonary disease: Joint ICS/NCCP (I) recommendations. Lung India, 2013, 30(3):228-267. doi: 10.4103/0970-2113.116248.
doi: 10.4103/0970-2113.116248 URL |
[19] |
Timmins SC, Coatsworth N, Palnitkar G, et al. Day-to-day variability of oscillatory impedance and spirometry in asthma and COPD. Respir Physiol Neurobiol, 2013, 185(2):416-424. doi: 10.1016/j.resp.2012.08.017.
doi: 10.1016/j.resp.2012.08.017 pmid: 22960661 |
[20] |
Hillas G, Perlikos F, Tsiligianni I, et al. Managing comorbidities in COPD. Int J Chron Obstruct Pulmon Dis, 2015, 10:95-109. doi: 10.2147/COPD.S54473.
doi: 10.2147/COPD.S54473 |
[21] |
$\check{C}$elutkien$\dot{e}$ J, Bal$\check{c}$iūnas M, Kablu$\check{c}$ko D, et al. Challenges of Treating Acute Heart Failure in Patients with Chronic Obstructive Pulmonary Disease. Card Fail Rev, 2017, 3(1):56-61. doi: 10.15420/cfr.2016:23:2.
doi: 10.15420/cfr.2016:23:2 URL |
[22] |
Khanam SS, Son JW, Lee JW, et al. Prognostic value of short-term follow-up BNP in hospitalized patients with heart failure. BMC Cardiovasc Disord, 2017, 17(1):215. doi: 10.1186/s12872-017-0632-0.
doi: 10.1186/s12872-017-0632-0 URL |
[23] |
McLellan J, Heneghan CJ, Perera R, et al. B-type natriuretic peptide-guided treatment for heart failure. Cochrane Database Syst Rev, 2016, 12(12):CD008966. doi: 10.1002/14651858.CD008966.pub2.
doi: 10.1002/14651858.CD008966.pub2 |
[24] |
叶伟杰, 莫蝶仪. 慢阻肺急性加重期与慢阻肺合并社区获得性肺炎患者临床表现对比分析. 内科, 2017, 12(6):756-759. doi: 10.16121/j.cnki.cn45-1347/r.2017.06.09.
doi: 10.16121/j.cnki.cn45-1347/r.2017.06.09 |
[25] |
汪志方, 徐金富, 罗艳蓉, 等. AECOPD与COPD合并CAP的差异队列研究. 同济大学学报(医学版), 2014, 35(4):59-62. doi: 10.3969/j.issn1008-0392.2014.04.012.
doi: 10.3969/j.issn1008-0392.2014.04.012 |
[1] | Yang Yarui, Guo Xujun, Wei Wei, He Juan, Li Shengbin, Zhong Tao, Gao Wanling, Liu Shoujiang, Liu Shengyuan. Awareness and factors associated with chronic obstructive pulmonary disease among permanent residents aged ≥40 years old in Nanshan District, Shenzhen [J]. Journal of Tuberculosis and Lung Disease, 2024, 5(6): 517-525. |
[2] | Hu Shasha, Chang Xiaoqing, Li Ying, Li Dandan. The value of RAGE, SP-D, ANG2, and HMGB1 in the assessment of severity and prognosis of community-acquired pneumonia [J]. Journal of Tuberculosis and Lung Disease, 2024, 5(6): 526-532. |
[3] | Zhu Yixing, Chang De. Current status and prospects of management of chronic respiratory diseases [J]. Journal of Tuberculosis and Lung Disease, 2024, 5(6): 567-572. |
[4] | Liu Weijian, Xu Yuxiang, Zhan Shenlin, Zhang Peize, Qin Hongjuan. Clinical characteristics of patients died of active tuberculosis with different ages in tuberculosis specialized hospital [J]. Journal of Tuberculosis and Lung Disease, 2024, 5(5): 445-452. |
[5] | Yuan Lirong, Yang Qinglong, Li Yuling, Li Lin, Deng Shasha, Li Shuhua. Effect of computerized cognitive behavioral therapy in the management of symptom cluster in patients with chronic obstructive pulmonary disease: a randomized controlled trial [J]. Journal of Tuberculosis and Lung Disease, 2024, 5(5): 476-483. |
[6] | Zhao Ruina, Li Shuhua, Cui Xiaohong, Gong Qiaoqiao, Pei Junli, Yuan Lirong. Distribution characteristics and influencing factors of pathogens in ventilator associated pneumonia [J]. Journal of Tuberculosis and Lung Disease, 2024, 5(4): 305-310. |
[7] | Cai Xiaoting, Wu Xiaoying, He Liqian, Jiang Kunhong. A study on the correlation between family doctor contract services and clinical characteristics of pulmonary tuberculosis patients [J]. Journal of Tuberculosis and Lung Disease, 2024, 5(4): 333-338. |
[8] | Wang Lin, Zhang Zinan. Current status and prospects of pulmonary rehabilitation in patients with chronic obstructive pulmonary disease [J]. Journal of Tuberculosis and Lung Disease, 2024, 5(3): 191-196. |
[9] | Zheng Xiaoxia, Zhu Xiaoxiao, Wu Yifan, Gu Fen. The correlation between symptom burden and quality of life in patients with chronic obstructive pulmonary disease [J]. Journal of Tuberculosis and Lung Disease, 2024, 5(3): 207-211. |
[10] | Qiu Qiaojing, Tao Yang, Shen Jiani, Xu Jiapin, Zhu Lihong, Gu Fen. Research of symptom groups of chronic obstructive pulmonary disease and their correlation with patient’s quality of life [J]. Journal of Tuberculosis and Lung Disease, 2024, 5(3): 219-224. |
[11] | Wu Shaozhu, Yu Xueying, Luo Yuanrong, Liu Yanfei, Ke Caixia. The effectiveness of multidisciplinary graded collaborative management on swallowing screening and intervention in patients with chronic obstructive pulmonary disease [J]. Journal of Tuberculosis and Lung Disease, 2024, 5(3): 230-235. |
[12] | Zhang Yidan, Gu Fen, Li Nannan. Current status and nursing research progress of long-term oxygen therapy for patients with chronic obstructive pulmonary disease [J]. Journal of Tuberculosis and Lung Disease, 2024, 5(3): 249-253. |
[13] | Qu Chunjin, Peng Jiayi, Liu Xinyi, Xiao Guanchen, Gu Fen, Li Nannan. Research progress on continuous nursing of patients with chronic obstructive pulmonary disease [J]. Journal of Tuberculosis and Lung Disease, 2024, 5(3): 254-259. |
[14] | Yuan Yonglong, Li Huimei, Ma Dedong. Metagenomic next-generation sequencing assisted in the diagnosis of psittacosis: a case report and literature review [J]. Journal of Tuberculosis and Lung Disease, 2024, 5(2): 113-119. |
[15] | Yan Yanfeng, Qi Wenxia, Cui Yonghui, Wei Caihong. Progress in the expression of long-stranded noncoding RNA and their role in chronic obstructive pulmonary disease [J]. Journal of Tuberculosis and Lung Disease, 2024, 5(2): 172-178. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||